End-of-day quote
Korea S.E.
06:00:00 2024-06-04 pm EDT
|
5-day change
|
1st Jan Change
|
7,350
KRW
|
-1.47%
|
|
-2.52%
|
-21.22%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
-
|
408,421
|
822,627
|
656,626
|
-
|
-
|
Enterprise Value (EV)
2 |
-
|
395.4
|
771.5
|
600.6
|
541.2
|
478.8
|
P/E ratio
|
0.88
x
|
14.2
x
|
21.2
x
|
14.8
x
|
10.2
x
|
8.18
x
|
Yield
|
-
|
-
|
-
|
0.75%
|
0.88%
|
0.95%
|
Capitalization / Revenue
|
-
|
5.01
x
|
6.95
x
|
4.31
x
|
3.32
x
|
2.66
x
|
EV / Revenue
|
-
|
4.85
x
|
6.52
x
|
3.94
x
|
2.74
x
|
1.94
x
|
EV / EBITDA
|
-
|
14
x
|
16.3
x
|
9.6
x
|
6.39
x
|
4.49
x
|
EV / FCF
|
-
|
27.8
x
|
32.4
x
|
21.9
x
|
10.4
x
|
7.55
x
|
FCF Yield
|
-
|
3.6%
|
3.09%
|
4.57%
|
9.6%
|
13.2%
|
Price to Book
|
-
|
7.16
x
|
8.29
x
|
4.58
x
|
3.19
x
|
2.29
x
|
Nbr of stocks (in thousands)
|
-
|
87,927
|
88,170
|
89,337
|
-
|
-
|
Reference price
3 |
2,675
|
4,645
|
9,330
|
7,350
|
7,350
|
7,350
|
Announcement Date
|
3/18/22
|
3/7/23
|
2/8/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
51.06
|
81.48
|
118.4
|
152.4
|
197.8
|
247.1
|
EBITDA
1 |
-
|
28.32
|
47.42
|
62.58
|
84.66
|
106.7
|
EBIT
1 |
-
|
27.03
|
46.04
|
60.26
|
81.95
|
103.9
|
Operating Margin
|
-
|
33.17%
|
38.9%
|
39.55%
|
41.44%
|
42.04%
|
Earnings before Tax (EBT)
1 |
-
|
18.21
|
47.72
|
56.04
|
81.83
|
101.7
|
Net income
1 |
-
|
16.59
|
38.83
|
44.08
|
64.07
|
79.94
|
Net margin
|
-
|
20.35%
|
32.81%
|
28.93%
|
32.4%
|
32.36%
|
EPS
2 |
3,025
|
327.0
|
441.0
|
497.4
|
721.0
|
898.4
|
Free Cash Flow
3 |
-
|
14,238
|
23,846
|
27,460
|
51,940
|
63,375
|
FCF margin
|
-
|
17,472.99%
|
20,146.7%
|
18,022.46%
|
26,264.06%
|
25,651.94%
|
FCF Conversion (EBITDA)
|
-
|
50,267.63%
|
50,288.62%
|
43,881.61%
|
61,348.62%
|
59,369.52%
|
FCF Conversion (Net income)
|
-
|
85,842.48%
|
61,405.2%
|
62,295.83%
|
81,071.8%
|
79,278.21%
|
Dividend per Share
2 |
-
|
-
|
-
|
55.25
|
65.00
|
69.80
|
Announcement Date
|
3/18/22
|
3/7/23
|
2/8/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
30.5
|
26.38
|
30.2
|
22.57
|
34.67
|
39.27
|
43.37
|
EBITDA
1 |
-
|
-
|
11.19
|
-
|
16.2
|
16.8
|
17.5
|
EBIT
1 |
-
|
9.532
|
10.49
|
6.634
|
12.5
|
15.57
|
19.83
|
Operating Margin
|
-
|
36.13%
|
34.75%
|
29.4%
|
36.06%
|
39.64%
|
45.73%
|
Earnings before Tax (EBT)
1 |
-
|
9.592
|
12.93
|
6.937
|
12.6
|
13.7
|
14.8
|
Net income
1 |
-
|
8.722
|
9.286
|
5.924
|
9.95
|
10.4
|
16.35
|
Net margin
|
-
|
33.06%
|
30.75%
|
26.25%
|
28.7%
|
26.49%
|
37.7%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/11/23
|
11/10/23
|
2/8/24
|
5/10/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
13
|
51.1
|
56.1
|
115
|
178
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
2 |
-
|
14,238
|
23,846
|
27,460
|
51,940
|
63,375
|
ROE (net income / shareholders' equity)
|
-
|
40%
|
49.7%
|
36.9%
|
35.3%
|
33.4%
|
ROA (Net income/ Total Assets)
|
-
|
27.3%
|
34.2%
|
24.1%
|
27.8%
|
26.2%
|
Assets
1 |
-
|
60.7
|
113.5
|
183.2
|
230.8
|
305.7
|
Book Value Per Share
3 |
-
|
649.0
|
1,126
|
1,606
|
2,307
|
3,211
|
Cash Flow per Share
3 |
-
|
-
|
295.0
|
675.0
|
877.0
|
1,100
|
Capex
1 |
-
|
0.54
|
2.11
|
4.33
|
3.06
|
5.38
|
Capex / Sales
|
-
|
0.67%
|
1.78%
|
2.84%
|
1.55%
|
2.18%
|
Announcement Date
|
3/18/22
|
3/7/23
|
2/8/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
7,350
KRW Average target price
12,875
KRW Spread / Average Target +75.17% Consensus |
1st Jan change
|
Capi.
|
---|
| -21.22% | 479M | | +75.69% | 12.57B | | +6.32% | 6.62B | | +14.03% | 5.45B | | -16.76% | 4.88B | | +20.13% | 4.29B | | -20.15% | 4.06B | | -22.44% | 2.93B | | +54.92% | 2.49B | | +1.49% | 2.06B |
Medical Equipment
|